Treatment for impotence gains FDA approval.
D000527:Alprostadil / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D007172:Erectile Dysfunction / Q000188:drug therapy*; D006801:Humans; D007267:Injections; D008297:Male; D010410:Penile Erection; D013997:Time Factors; D014481:United States; D014486:United States Food and Drug Administration
D000527:Alprostadil